Changeflow GovPing Healthcare & Life Sciences Patent Application: Compositions and Methods fo...
Routine Notice Added Draft

Patent Application: Compositions and Methods for Reducing RNA Levels

Favicon for changeflow.com USPTO Patent Applications - Biotech (C12N)
Published
Detected
Email

Summary

The USPTO has published a new patent application (US20260085311A1) detailing compositions and methods for reducing RNA levels and treating diseases caused by toxic gain-of-function proteins. The application was filed on June 20, 2023.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

This document is a publication of a patent application filed with the USPTO, specifically application number US20260085311A1. The application, titled "Compositions and Methods for Reducing RNA Levels," describes methods for reducing RNA transcript levels and treating diseases resulting from toxic gain-of-function proteins. It was filed on June 20, 2023, by inventors Liana Lareau, Fyodor Urnov, and Ma. Carmelle Catamura.

As this is a patent application, it does not impose immediate regulatory obligations or compliance deadlines on regulated entities. However, it represents potential future intellectual property in the biotechnology and pharmaceutical sectors. Companies involved in RNA-based therapeutics or disease treatment should be aware of this filing as it may impact future research, development, and patent landscapes.

Archived snapshot

Mar 27, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

COMPOSITIONS AND METHODS FOR REDUCING RNA LEVELS

Application US20260085311A1 Kind: A1 Mar 26, 2026

Inventors

Liana Lareau, Fyodor Urnov, Ma. Carmelle Catamura

Abstract

The present disclosure provides methods for reducing the level of an RNA transcript from a target nucleic acid. The present disclosure provides methods of treating a disease that results from or is caused by a toxic gain-of-function protein. The present disclosure provides systems and compositions for carrying out a method of the present disclosure.

CPC Classifications

C12N 15/113 A61K 38/00 A61K 48/00 C12N 9/1276 C12N 9/222 C12N 9/78 C12N 15/52 C12N 15/63 C12Y 207/07049 C12Y 305/04004 C12Y 305/04005 C12N 2310/20

Filing Date

2023-06-20

Application No.

18876098

View original document →

Named provisions

Abstract Inventors CPC Classifications

Get daily alerts for USPTO Patent Applications - Biotech (C12N)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
June 20th, 2023
Instrument
Notice
Legal weight
Non-binding
Stage
Draft
Change scope
Minor
Document ID
US20260085311A1

Who this affects

Applies to
Drug manufacturers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing 3254.1 Biotechnology
Activity scope
Drug Development Therapeutic Research
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Legal
Compliance frameworks
FDA 21 CFR Part 11
Topics
Biotechnology Intellectual Property

Get alerts for this source

We'll email you when USPTO Patent Applications - Biotech (C12N) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!